Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Precedings
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • RSS feed
  1. nature
  2. nature precedings
  3. articles
  4. article
Aven and Survivin Expression in Egyptian Acute Leukemia and Their Relation to Apoptosis
Download PDF
Download PDF
  • Manuscript
  • Open access
  • Published: 23 September 2009

Aven and Survivin Expression in Egyptian Acute Leukemia and Their Relation to Apoptosis

  • Magda Assem1,
  • Thorraya Abedel- ALhameid2,
  • Gihan A-Basset1,
  • Amany Hilal2,
  • Mahmoud Kamel1,
  • Iman Khalil1,
  • Nahla Alsharkawey1 &
  • …
  • Ayman Metwally3 

Nature Precedings (2009)Cite this article

  • 279 Accesses

  • Metrics details

Abstract

Background:

Several anti apoptotic signals have been recently identified. Aven and Survivin are broadly expressed and are conserved in mammalian species. Patients and Methods: 39 AML and 25 ALL were tested. Aven and Survivin expression were detected by RT-PCR. DNA fragmentation was carried out daily after treatment..

Results:

Survivin was expressed (P=0.06) more in AML (74%) than in ALL (52%). While, Aven was equally expressed in both leukemias. Patients were categorized into 3 groups based on DNA fragmentation. Absence of Aven significantly (p&x2039;0.001) contributed to DNA fragmentation,but Survivin did not contribute as much. None of the concordant both positive Survivin and Aven were in group III (the good 5 day fragmentation, (P< 0.001). Survivin was statistically related to CD7 expression (P<0.001) in AML only. There was a significant dissociation between Aven and Survivin in AML (p=0.03) and near significant dissociation in ALL (p=0.07). Conclusion: Aven seems to be more important as an inhibitor of apoptosis than survivin in acute leukemia. The presence of both confers a survival disadvantage and a significantly worse DNA fragmentation pattern suggesting a synergistic inhibition of apoptosis. The highly significant relation between CD7 and survivin expression might suggest their involvement in a common signal transduction pathway.

Similar content being viewed by others

Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target

Article Open access 30 October 2023

The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(6;11)

Article Open access 05 August 2021

AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms

Article Open access 30 July 2021

Article PDF

Author information

Authors and Affiliations

  1. Clinical Pathology, National Cancer Institute, Cairo University https://www.nature.com/nature

    Magda Assem, Gihan A-Basset, Mahmoud Kamel, Iman Khalil & Nahla Alsharkawey

  2. Medical Oncology, National Cancer Institute, Cairo University https://www.nature.com/nature

    Thorraya Abedel- ALhameid & Amany Hilal

  3. Misr University for Science and Technology https://www.nature.com/nature

    Ayman Metwally

Authors
  1. Magda Assem
    View author publications

    Search author on:PubMed Google Scholar

  2. Thorraya Abedel- ALhameid
    View author publications

    Search author on:PubMed Google Scholar

  3. Gihan A-Basset
    View author publications

    Search author on:PubMed Google Scholar

  4. Amany Hilal
    View author publications

    Search author on:PubMed Google Scholar

  5. Mahmoud Kamel
    View author publications

    Search author on:PubMed Google Scholar

  6. Iman Khalil
    View author publications

    Search author on:PubMed Google Scholar

  7. Nahla Alsharkawey
    View author publications

    Search author on:PubMed Google Scholar

  8. Ayman Metwally
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Mahmoud Kamel.

Rights and permissions

Creative Commons Attribution 3.0 License.

Reprints and permissions

About this article

Cite this article

Assem, M., Abedel- ALhameid, T., A-Basset, G. et al. Aven and Survivin Expression in Egyptian Acute Leukemia and Their Relation to Apoptosis. Nat Prec (2009). https://doi.org/10.1038/npre.2009.3771.1

Download citation

  • Received: 16 September 2009

  • Accepted: 23 September 2009

  • Published: 23 September 2009

  • DOI: https://doi.org/10.1038/npre.2009.3771.1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • survivin
  • Aven
  • AML
  • ALL and DNA fragmentation
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Precedings (Nat Preced)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing